Added GLP-1 metabolic meds (Ozempic/Wegovy/Mounjaro/Zepbound) + evidence + glossary terms
Added GLP-1 metabolic meds (Ozempic/Wegovy/Mounjaro/Zepbound) + evidence + glossary terms
Site updates
A running log of data refreshes, structured data tweaks, and new educational content rolling out on PsychMed.
Subscribe via RSSSubstance-use treatment + harm-reduction profiles added
Added new medication guides covering opioid, alcohol, and tobacco use disorders, including buprenorphine, buprenorphine-naloxone, methadone, naltrexone (oral and extended-release), naloxone rescue, lofexidine, acamprosate, disulfiram, nicotine replacement therapy, and varenicline.
Add propranolol, gabapentin, pregabalin profiles
Add propranolol, gabapentin, pregabalin profiles
Added temazepam, triazolam, oxazepam, chlordiazepoxide
Added temazepam, triazolam, oxazepam, chlordiazepoxide
Sleep & anxiety coverage expanded + evidence library refreshed
Added new medication guides (alprazolam, diazepam, eszopiclone, prazosin, zolpidem, ramelteon, suvorexant, lemborexant, daridorexant, zaleplon), populated the Evidence library with curated guidelines/trials/meta-analyses, and refreshed Support hub resource links.
Antidepressant profile collection completed
Sertraline, tranylcypromine, venlafaxine, vilazodone, and vortioxetine now have the same full guides as our antipsychotic pages—plain-language overviews, key dosing tips, printable takeaways, and quick comparison notes.
Antidepressant and MAOI coverage added
We brought the SSRI/SNRI group, atypical antidepressants, and MAOIs online. Each page now lists brand names, fresh DailyMed links, and practical monitoring reminders so you can compare options at a glance.
Mood stabilizers and VMAT2 inhibitors onboarded
Lithium, valproate, carbamazepine, lamotrigine, oxcarbazepine, valbenazine, and deutetrabenazine now feature clear safety checklists, DailyMed label links, and level-monitoring guidance to support everyday prescribing decisions.
Core antipsychotic catalog published
Our launch covers haloperidol, risperidone, paliperidone, olanzapine, quetiapine, brexpiprazole, cariprazine, lurasidone, lumateperone, ziprasidone, asenapine, and clozapine. Each profile includes balanced dosing ranges, safety watch-outs, and direct label links.